References
- Jantz MA, Antony VB. Pleural fibrosis. Clin Chest Med. 2006;27(2):181–191.
- Mahjoubi I, Khalil A, Carette MF. [Inflammation and pleural fibrosis]. Rev Pneumol Clin. 2006;62(2):97–110.
- Mutsaers SE, Prele CM, Brody AR, et al. Pathogenesis of pleural fibrosis. Respirology. 2004;9(4):428–440.
- Mutsaers SE. The mesothelial cell. Int J Biochem Cell Biol. 2004;36(1):9–16.
- Batra H, Antony VB. Pleural mesothelial cells in pleural and lung diseases. J Thorac Dis. 2015;7(6):964–980.
- Kawanishi K. Diverse properties of the mesothelial cells in health and disease. Pleura Peritoneum. 2016;1(2):79–89.
- Meng XM, Nikolic-Paterson DJ, Lan HY. TGF-β: the master regulator of fibrosis. Nat Rev Nephrol. 2016;12(6):325–338.
- Kim KK, Sheppard D, Chapman HA. TGF-beta1 signaling and tissue fibrosis. Cold Spring Harb Perspect Biol. 2018;10(4):a022293–a022326.
- Decologne N, Kolb M, Margetts PJ, et al. TGF-beta1 induces progressive pleural scarring and subpleural fibrosis. J Immunol. 2007;179(9):6043–6051.
- Jiang N, Zhang Z, Shao X, et al. Blockade of thrombospondin-1 ameliorates high glucose-induced peritoneal fibrosis through downregulation of TGF-β1/Smad3 signaling pathway. J Cell Physiol. 2020;235(1):364–379.
- Wang M, Xiong L, Jiang LJ, et al. miR-4739 mediates pleural fibrosis by targeting bone morphogenetic protein 7. EBioMedicine. 2019;41:670–682.
- Marx S, Dal Maso T, Chen JW, et al. Transmembrane (TMEM) protein family members: poorly characterized even if essential for the metastatic process. Semin Cancer Biol. 2020;60:96–106.
- Schmit K, Michiels C. TMEM proteins in cancer: a review. Front Pharmacol. 2018;9:1345–1357.
- Cai SP, Cheng XY, Chen PJ, et al. Transmembrane protein 88 attenuates liver fibrosis by promoting apoptosis and reversion of activated hepatic stellate cells. Mol Immunol. 2016;80:58–67.
- Zhao H, Lu F, Cui S, et al. TMEM88 inhibits extracellular matrix expression in keloid fibroblasts. Biomed Pharmacother. 2017;95:1436–1440.
- Li H, Wang Y, Chen B, et al. TMEM88 inhibits fibrosis in renal proximal tubular epithelial cells by suppressing the transforming growth factor-β1/Smad signaling pathway. RSC Adv. 2019;9(12):6928–6934.
- Strippoli R, Moreno-Vicente R, Battistelli C, et al. Molecular mechanisms underlying peritoneal EMT and fibrosis. Stem Cells Int. 2016;2016:3543678.
- Kriz W, Kaissling B, Le Hir M. Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy? J Clin Invest. 2011;121(2):468–474.
- Hata A, Chen YG. TGF-beta signaling from receptors to Smads. Cold Spring Harb Perspect Biol. 2016;8(9):a022061–a022091.
- Hu HH, Chen DQ, Wang YN, et al. New insights into TGF-β/Smad signaling in tissue fibrosis. Chem Biol Interact. 2018;292:76–83.
- Jones RE, Foster DS, Hu MS, et al. Wound healing and fibrosis: current stem cell therapies. Transfusion. 2019;59(S1):884–892.
- Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol. 2008;214(2):199–210.
- Walraven M, Hinz B. Therapeutic approaches to control tissue repair and fibrosis: extracellular matrix as a game changer. Matrix Biol. 2018;71-72:205–224.
- Sutariya B, Jhonsa D, Saraf MN. TGF-β: the connecting link between nephropathy and fibrosis. Immunopharmacol Immunotoxicol. 2016;38(1):39–49.
- Lichtman MK, Otero-Vinas M, Falanga V. Transforming growth factor beta (TGF-β) isoforms in wound healing and fibrosis. Wound Repair Regen. 2016;24(2):215–222.
- Nieto MA, Huang RY, Jackson RA, et al. EMT: 2016. Cell. 2016;166(1):21–45.
- Thiery JP. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol. 2003;15(6):740–746.
- Lim J, Thiery JP. Epithelial-mesenchymal transitions: insights from development. Development. 2012;139(19):3471–3486.
- Gonzalez DM, Medici D. Signaling mechanisms of the epithelial-mesenchymal transition. Sci Signal. 2014;7(344):re8.
- Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest. 2009;119(6):1420–1428.
- Vander Ark A, Cao J, Li X. TGF-β receptors: in and beyond TGF-β signaling. Cell Signal. 2018;52:112–120.
- Lodyga M, Hinz B. TGF-β1 – a truly transforming growth factor in fibrosis and immunity. Semin Cell Dev Biol. 2020;101:123–139.